BioMarin Pharmaceutical Current Ratio 2006-2018 | BMRN

Current and historical current ratio for BioMarin Pharmaceutical (BMRN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. BioMarin Pharmaceutical current ratio for the three months ending September 30, 2018 was 2.87.
BioMarin Pharmaceutical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $2.41B $0.84B 2.87
2018-06-30 $2.28B $0.81B 2.83
2018-03-31 $2.24B $0.77B 2.90
2017-12-31 $2.21B $0.82B 2.70
2017-09-30 $2.05B $0.42B 4.91
2017-06-30 $1.46B $0.37B 3.90
2017-03-31 $1.35B $0.34B 3.98
2016-12-31 $1.42B $0.44B 3.24
2016-09-30 $1.67B $0.38B 4.42
2016-06-30 $1.11B $0.37B 3.03
2016-03-31 $0.99B $0.39B 2.56
2015-12-31 $1.09B $0.45B 2.45
2015-09-30 $1.18B $0.39B 3.01
2015-06-30 $1.21B $0.35B 3.49
2015-03-31 $1.52B $0.31B 4.98
2014-12-31 $1.40B $0.24B 5.93
2014-09-30 $1.08B $0.21B 5.22
2014-06-30 $1.22B $0.17B 7.32
2014-03-31 $1.25B $0.16B 7.99
2013-12-31 $1.14B $0.18B 6.21
2013-09-30 $0.71B $0.17B 4.26
2013-06-30 $0.72B $0.14B 5.07
2013-03-31 $0.72B $0.14B 5.02
2012-12-31 $0.74B $0.17B 4.36
2012-09-30 $0.72B $0.14B 5.33
2012-06-30 $0.68B $0.12B 5.68
2012-03-31 $0.51B $0.12B 4.29
2011-12-31 $0.47B $0.09B 4.99
2011-09-30 $0.49B $0.08B 5.85
2011-06-30 $0.51B $0.08B 6.27
2011-03-31 $0.50B $0.08B 6.63
2010-12-31 $0.50B $0.08B 6.01
2010-09-30 $0.55B $0.09B 6.02
2010-06-30 $0.52B $0.08B 6.22
2010-03-31 $0.50B $0.08B 6.36
2009-12-31 $0.47B $0.08B 5.99
2009-09-30 $0.52B $0.06B 8.12
2009-06-30 $0.51B $0.06B 8.45
2009-03-31 $0.71B $0.13B 5.65
2008-12-31 $0.74B $0.13B 5.67
2008-09-30 $0.70B $0.12B 5.77
2008-06-30 $0.70B $0.06B 11.07
2008-03-31 $0.68B $0.05B 12.83
2007-12-31 $0.64B $0.06B 10.47
2007-09-30 $0.64B $0.05B 13.07
2007-06-30 $0.64B $0.05B 14.39
2007-03-31 $0.32B $0.04B 8.26
2006-12-31 $0.33B $0.05B 7.26
2006-09-30 $0.34B $0.04B 7.85
2006-06-30 $0.35B $0.04B 9.07
2006-03-31 $0.38B $0.06B 6.66
2005-12-31 $0.07B $0.04B 1.71
2005-09-30 $0.08B $0.04B 1.86
2005-06-30 $0.04B $0.04B 0.90
2005-03-31 $0.05B $0.05B 1.06
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.287B $1.314B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.175B 14.15
Gilead Sciences (GILD) United States $87.410B 10.52
Biogen (BIIB) United States $64.370B 13.03
Celgene (CELG) United States $46.675B 9.06
Illumina (ILMN) United States $44.259B 51.56
Vertex Pharmaceuticals (VRTX) United States $40.828B 71.32
Regeneron Pharmaceuticals (REGN) United States $36.498B 18.49
Alexion Pharmaceuticals (ALXN) United States $26.062B 17.83
Incyte (INCY) United States $13.532B 374.06
Seattle Genetics (SGEN) United States $8.999B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.107B 51.83
Exact Sciences (EXAS) United States $7.955B 0.00
Sarepta Therapeutics (SRPT) United States $7.830B 0.00
QIAGEN (QGEN) Netherlands $7.739B 24.75
Alnylam Pharmaceuticals (ALNY) United States $7.341B 0.00
BeiGene (BGNE) Cayman Islands $6.765B 0.00
Bluebird Bio (BLUE) United States $6.364B 0.00
Bio-Techne Corp (TECH) United States $5.904B 39.88
Exelixis (EXEL) United States $5.283B 14.98
Alkermes (ALKS) Ireland $5.193B 3342.00
Galapagos (GLPG) Belgium $5.072B 0.00
Amarin (AMRN) Ireland $5.066B 0.00
Immunomedics (IMMU) United States $3.555B 0.00
Emergent Biosolutions (EBS) United States $3.553B 29.93
Horizon Pharma Public (HZNP) Ireland $3.448B 14.19
MorphoSys AG Unsponsored ADR (MOR) Germany $3.360B 0.00
Array BioPharma (ARRY) United States $3.249B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.166B 0.00
Ligand Pharmaceuticals (LGND) United States $3.164B 24.20
Guardant Health (GH) United States $2.979B 0.00
Allogene Therapeutics (ALLO) United States $2.943B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.743B 0.00
Repligen (RGEN) United States $2.697B 84.25
Genomic Health (GHDX) United States $2.628B 88.72
Akcea Therapeutics (AKCA) United States $2.619B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.579B 0.00
China Biologic Products (CBPO) China $2.502B 17.81
Ascendis Pharma (ASND) Denmark $2.406B 0.00
Myriad Genetics (MYGN) United States $2.370B 23.48
Acceleron Pharma (XLRN) United States $2.300B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.281B 0.00
Allakos (ALLK) United States $2.280B 0.00
Blueprint Medicines (BPMC) United States $2.277B 0.00
Halozyme Therapeutics (HALO) United States $2.258B 50.39
MyoKardia (MYOK) United States $2.231B 0.00
REGENXBIO (RGNX) United States $2.181B 29.25
Arena Pharmaceuticals (ARNA) United States $1.942B 0.00
Amicus Therapeutics (FOLD) United States $1.895B 0.00
AnaptysBio (ANAB) United States $1.847B 0.00
Reata Pharmaceuticals (RETA) United States $1.822B 0.00
Denali Therapeutics (DNLI) United States $1.760B 0.00
Global Blood Therapeutics (GBT) United States $1.724B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.699B 0.00
Innoviva (INVA) United States $1.660B 9.39
Atara Biotherapeutics (ATRA) United States $1.622B 0.00
Cambrex (CBM) United States $1.603B 11.97
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.598B 0.00
Medicines (MDCO) United States $1.510B 0.00
Rubius Therapeutics (RUBY) United States $1.504B 0.00
Aimmune Therapeutics (AIMT) United States $1.479B 0.00
Spark Therapeutics (ONCE) United States $1.464B 0.00
NeoGenomics (NEO) United States $1.451B 120.00
G1 THERAPEUTICS (GTHX) United States $1.419B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.399B 0.00
Mirati Therapeutics (MRTX) United States $1.343B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.307B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Insmed (INSM) United States $1.287B 0.00
Myovant Sciences (MYOV) United Kingdom $1.272B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.245B 98.88
Editas Medicine (EDIT) United States $1.222B 0.00
WAVE Life Sciences (WVE) Singapore $1.201B 0.00
Solid Biosciences (SLDB) United States $1.170B 0.00
IMMURON LTD (IMRN) Australia $1.141B 0.00
Lion Biotechnologies (IOVA) United States $1.084B 0.00
Sangamo Therapeutics (SGMO) United States $1.077B 0.00
Retrophin (RTRX) United States $1.033B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.998B 0.00
UniQure (QURE) Netherlands $0.979B 0.00
Audentes Therapeutics (BOLD) United States $0.977B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.953B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.937B 0.00
Clovis Oncology (CLVS) United States $0.916B 0.00
Acorda Therapeutics (ACOR) United States $0.883B 11.18
Puma Biotechnology (PBYI) United States $0.882B 0.00
DBV Technologies (DBVT) France $0.881B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.875B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.869B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.847B 0.00
Cellectis (CLLS) France $0.841B 0.00
Intra-Cellular Therapies (ITCI) United States $0.839B 0.00
Viking Therapeutics (VKTX) United States $0.837B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.836B 0.00
Apellis Pharmaceuticals (APLS) United States $0.809B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.808B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.801B 0.00
Fate Therapeutics (FATE) United States $0.794B 0.00
Coherus BioSciences (CHRS) United States $0.790B 0.00
Athenex (ATNX) United States $0.779B 0.00
Revance Therapeutics (RVNC) United States $0.752B 0.00
Aptinyx (APTX) United States $0.751B 0.00
Heska (HSKA) United States $0.746B 61.03
ProQR Therapeutics (PRQR) Netherlands $0.741B 0.00
Dynavax Technologies (DVAX) United States $0.724B 0.00
Vericel (VCEL) United States $0.722B 0.00
Intellia Therapeutics (NTLA) United States $0.711B 0.00
Cara Therapeutics (CARA) United States $0.697B 0.00
AC Immune SA (ACIU) Switzerland $0.655B 0.00
Novavax (NVAX) United States $0.643B 0.00
UROGEN PHARMA (URGN) Israel $0.641B 0.00
TWIST BIOSCIENC (TWST) United States $0.640B 0.00
Gritstone Oncology (GRTS) United States $0.637B 0.00
ANI Pharmaceuticals (ANIP) United States $0.634B 12.12
AMAG Pharmaceuticals (AMAG) United States $0.622B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.617B 0.00
InflaRx (IFRX) Germany $0.609B 0.00
Principia Biopharma (PRNB) United States $0.592B 0.00
Epizyme (EPZM) United States $0.572B 0.00
CytomX Therapeutics (CTMX) United States $0.571B 0.00
Arvinas (ARVN) United States $0.571B 0.00
Senesco Technologies (ELOX) United States $0.564B 0.00
Scholar Rock Holding (SRRK) United States $0.557B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.557B 0.00
AVROBIO (AVRO) United States $0.528B 0.00
Eidos Therapeutics (EIDX) United States $0.522B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.517B 0.00
BeyondSpring (BYSI) United States $0.514B 0.00
UNITY Biotechnology (UBX) $0.511B 0.00
Arcus Biosciences (RCUS) United States $0.490B 0.00
Anika Therapeutics (ANIK) United States $0.482B 19.97
Inovio Pharmaceuticals (INO) United States $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.467B 0.00
Prothena (PRTA) Ireland $0.462B 0.00
RA PHARMCTL INC (RARX) United States $0.462B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.459B 0.00
Kura Oncology (KURA) United States $0.454B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.441B 0.00
Mesoblast (MESO) Australia $0.436B 0.00
ObsEva SA (OBSV) Switzerland $0.435B 0.00
Kindred Biosciences (KIN) United States $0.429B 0.00
Sinovac Biotech (SVA) China $0.427B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.425B 0.00
PDL BioPharma (PDLI) United States $0.423B 6.90
Replimune (REPL) United States $0.421B 0.00
Sorrento Therapeutics (SRNE) United States $0.410B 67.00
Five Prime Therapeutics (FPRX) United States $0.403B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.402B 0.00
Cytokineticsorporated (CYTK) United States $0.390B 0.00
MediciNova (MNOV) United States $0.389B 0.00
Zealand Pharma (ZEAL) Denmark $0.385B 4.24
Zymeworks (ZYME) Canada $0.384B 0.00
Verastem (VSTM) United States $0.372B 0.00
Abeona Therapeutics (ABEO) United States $0.367B 0.00
Osiris Therapeutics (OSIR) United States $0.365B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
ResTORbio (TORC) United States $0.343B 0.00
Merus (MRUS) Netherlands $0.341B 0.00
Stemline Therapeutics (STML) United States $0.335B 0.00
Seres Therapeutics (MCRB) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Liquidia Technologies (LQDA) United States $0.325B 0.00
LogicBio Therapeutics (LOGC) United States $0.310B 0.00
Krystal Biotech (KRYS) United States $0.297B 0.00
Evelo Biosciences (EVLO) United States $0.293B 0.00
Kadmon Holdings (KDMN) United States $0.288B 0.00
Albireo Pharma (ALBO) United States $0.287B 0.00
Kodiak Sciences (KOD) United States $0.286B 0.00
Geron (GERN) United States $0.283B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.272B 0.00
MannKind (MNKD) United States $0.270B 0.00
Athersys (ATHX) United States $0.266B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.263B 0.00
Agenus (AGEN) United States $0.259B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.258B 0.00
BioDelivery Sciences (BDSI) United States $0.257B 0.00
Syros Pharmaceuticals (SYRS) United States $0.255B 0.00
Magenta Therapeutics (MGTA) United States $0.253B 0.00
Equillium (EQ) United States $0.252B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.251B 0.00
Arbutus Biopharma (ABUS) Canada $0.247B 0.00
Aduro Biotech (ADRO) United States $0.242B 0.00
Celyad SA (CYAD) Belgium $0.242B 0.00
Urovant Sciences (UROV) United States $0.241B 0.00
Celcuity (CELC) United States $0.239B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.238B 0.00
Strongbridge Biopharma (SBBP) United States $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
TOCAGEN INC (TOCA) United States $0.233B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Sutro Biopharma (STRO) United States $0.227B 0.00
Unum Therapeutics (UMRX) United States $0.223B 0.00
Synlogic (SYBX) United States $0.222B 0.00
Axovant Sciences (AXON) United Kingdom $0.219B 0.00
BioTime (BTX) United States $0.215B 0.00
Proteostasis Therapeutics (PTI) United States $0.209B 0.00
Kamada (KMDA) Israel $0.207B 19.04
Kala Pharmaceuticals (KALA) United States $0.206B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.206B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.205B 0.00
Idera Pharmaceuticals (IDRA) United States $0.198B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.191B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.187B 0.00
ChromaDex (CDXC) United States $0.187B 0.00
Intec Pharma (NTEC) Israel $0.184B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.177B 0.00
Allena Pharmaceuticals (ALNA) United States $0.167B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.165B 0.00
NantKwest (NK) United States $0.165B 0.00
Compugen (CGEN) Israel $0.161B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.161B 0.00
PSivida (EYPT) United States $0.154B 0.00
XBiotech (XBIT) United States $0.150B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Menlo Therapeutics (MNLO) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.148B 0.00
Cerecor (CERC) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Spero Therapeutics (SPRO) United States $0.141B 0.00
Palatin Technologies (PTN) United States $0.140B 17.25
Pfenex (PFNX) United States $0.138B 0.00
Selecta Biosciences (SELB) United States $0.133B 0.00
Eleven Biotherapeutics (SESN) United States $0.132B 0.00
Cohbar (CWBR) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.121B 0.00
Mersana Therapeutics (MRSN) United States $0.119B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.118B 0.00
XOMA (XOMA) United States $0.118B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.117B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.117B 0.00
Organovo Holdings (ONVO) United States $0.110B 0.00
Mustang Bio (MBIO) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Motif Bio Plc (MTFB) United States $0.105B 0.00
Cue Biopharma (CUE) United States $0.104B 0.00
Signal Genetics (MGEN) United States $0.104B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.100B 0.00
OVID THERAPEUTC (OVID) United States $0.099B 0.00
Cidara Therapeutics (CDTX) United States $0.099B 0.00
Anavex Life Sciences (AVXL) United States $0.098B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Provention Bio (PRVB) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cocrystal Pharma (COCP) United States $0.087B 96.67
Orgenesis (ORGS) United States $0.086B 0.00
Aptose Biosciences (APTO) Canada $0.082B 0.00
Cel-Sci (CVM) United States $0.080B 0.00
Fortress Biotech (FBIO) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
BioXcel Therapeutics (BTAI) United States $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.077B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Ophthotech (OPHT) United States $0.076B 0.00
VolitionRX (VNRX) Singapore $0.076B 0.00
ITUS (ANIX) United States $0.072B 0.00
Monster Digital (INNT) United States $0.072B 0.00
Asterias Biotherapeutics (AST) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
Versartis (ARAV) United States $0.066B 5.81
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Evogene (EVGN) Israel $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
PHASEBIO PHARMA (PHAS) United States $0.061B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.061B 0.00
Clearside Biomedical (CLSD) United States $0.058B 0.00
Aptevo Therapeutics (APVO) United States $0.057B 0.00
Sophiris Bio (SPHS) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.055B 0.00
Celldex Therapeutics (CLDX) United States $0.055B 0.00
Bellerophon Therapeutics (BLPH) United States $0.053B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.053B 8.56
Oncobiologics (ONS) United States $0.053B 0.00
Leap Therapeutics (LPTX) United States $0.052B 0.00
Trevena (TRVN) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.050B 9.44
OncoSec Medical (ONCS) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.041B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
TRACON Pharmaceuticals (TCON) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Celsion (CLSN) United States $0.034B 0.00
GTx (GTXI) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
VIVUS (VVUS) United States $0.032B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Histogenics (HSGX) United States $0.028B 0.00
Therapix Biosciences (TRPX) Israel $0.027B 10.13
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.022B 0.00
CytRx (CYTR) United States $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Arsanis (ASNS) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Oragenics (OGEN) United States $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.005B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00